AptarGroup, Inc. 10-Q Summary: Quarter Ended September 30, 1999
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 1999, for AptarGroup, Inc., a Delaware corporation headquartered in Crystal Lake, Illinois. The company manufactures and distributes dispensing systems for the pharmaceutical, personal care, and food markets. As of November 10, 1999, there were 36,451,175 shares of common stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 1999 | Nine Months Ended Sept 30, 1999 |
|---|---|---|
| Net Sales | $210.5 million | $617.6 million |
| Operating Income | $28.9 million | $81.5 million |
| Net Income | $12.9 million | $43.3 million |
| Diluted EPS | $0.35 | $1.17 |
| Operating Margin | 13.7% | 13.2% |
| Cash Flow from Operations (9mo) | $93.0 million | |
| Total Debt (Long-term + Current) | $243.7 million | |
| Cash and Equivalents | $32.0 million | |
| Net Debt to Capitalization | 35.2% |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15% for the quarter and 15% for the nine-month period compared to 1998. Acquisitions contributed $26 million and $81 million to the increases, respectively. Organic growth was partially offset by a stronger U.S. dollar.
- Profitability: Operating income rose 14% for the quarter and 12% for the nine-month period. However, Net Income decreased 11% for the quarter due to a one-time charge.
- Acquisitions: The company acquired Emson Research, Inc. (Q1 1999) and three other entities (Q3 1999), significantly increasing goodwill and long-term debt.
- One-Time Charges: A $3.3 million charge for purchased in-process research and development (IPR&D) related to the Microflow acquisition reduced net income for the quarter and nine-month period.
- Debt Structure: Long-term obligations increased from $80.9 million (Dec 31, 1998) to $235.4 million (Sept 30, 1999) to fund acquisitions, including a new $107 million private debt placement.
Guidance, Outlook, and Risks
- Capital Expenditures: Management anticipates total capital expenditures for 1999 to be approximately $85 million to $90 million.
- Share Repurchase: On October 20, 1999, the Board authorized the repurchase of up to 1,000,000 shares, dependent on market conditions.
- Dividends: A quarterly dividend of $0.05 per share was declared, payable November 23, 1999.
- Year 2000 (Y2K) Risk: The company is in the final phase of its Y2K readiness program. While no material disruption is currently anticipated, a worst-case scenario involving facility interruptions could materially impact operations. Estimated project costs are $2.7 million, mostly incurred.
- Foreign Exchange: A significant portion of operations is in Europe. A strengthening U.S. dollar negatively impacts reported sales and income through translation effects.
- Accounting Changes: The company is assessing the impact of SFAS No. 133 regarding derivative instruments, with implementation required for fiscal quarters beginning after June 15, 2000.
Investor Verification Checklist
- Verify the commercial viability and projected timeline for the Microflow electronic aerosol delivery system, given the $3.3 million immediate write-off of IPR&D.
- Monitor the integration of the Emson Research acquisition and its contribution to the North American perfume and personal care pump markets.
- Assess the impact of the new $107 million debt placement on future interest coverage ratios and cash flow availability.
- Track the progress of the Y2K contingency planning phase to ensure no operational disruptions occur in late 1999 or early 2000.
- Review the effectiveness of hedging strategies against foreign currency fluctuations, particularly regarding the Euro and other European currencies.